<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34865941</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1476</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Auris, nasus, larynx</Title>
          <ISOAbbreviation>Auris Nasus Larynx</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Survey of nebulizer therapy for nasal inflammatory diseases in Japan before and during the COVID-19 pandemic.</ArticleTitle>
        <Pagination>
          <StartPage>504</StartPage>
          <EndPage>510</EndPage>
          <MedlinePgn>504-510</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anl.2021.11.007</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0385-8146(21)00269-8</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Nebulizer therapy is an effective and safe topical treatment for rhinosinusitis and is frequently used by otolaryngologists in Japan. However, treatment methods used vary among regions and according to doctors' preferences. In this study, we aimed to investigate the use of nebulizer therapy for rhinosinusitis. Administration of nebulizer therapy has been affected by the coronavirus disease 2019 (COVID-19) pandemic. Thus, we also investigated the difference in the prevalence of nebulizer use before and during the pandemic.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Between February and September 2016 and in January 2021, we administered questionnaire surveys on nebulizer treatment for rhinosinusitis to otorhinolaryngologists, who were members of the Oto-Rhino-Laryngological Society of Japan, in Aomori, Saitama, Mie, Fukui, Shiga, Okayama, and Kagoshima prefectures.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">More than 90% of the otorhinolaryngologists performed nebulizer treatment for rhinosinusitis in 2016. In April 2020 (the first wave of the COVID-19 pandemic), the use rate decreased to 20%, but in January 2021, the use rate increased to 60%. Jet nebulizers were the most frequently used type. One-third of the otolaryngologists enlarged the natural opening of the paranasal sinuses in more than half of their patients by using vasoconstrictors. Cefmenoxime and betamethasone were the most commonly used antibiotics and steroids, respectively.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Because it is important to perform nasal pretreatment and strict disinfection of nebulizer equipment, it is clear that education of otorhinolaryngologists as well as paramedical personnel is required to ensure safe and effective use of nebulizer therapy in Japan.</AbstractText>
          <CopyrightInformation>Copyright Â© 2021. Published by Elsevier B.V.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hyo</LastName>
            <ForeName>Yukiyoshi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology - Head and Neck Surgery, Kawasaki Medical School, Kurashiki, Japan; HYO ENT Clinic, Kyoto, Japan. Electronic address: yuki-hyo@med.kawasaki-m.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujieda</LastName>
            <ForeName>Shigeharu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Otorhinolaryngology - Head &amp; Neck Surgery, Department of Sensory and Locomotor Medicine, Faculty of Medical Science, University of Fukui, Fukui, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsubara</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Hirosaki University, Hirosaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takeuchi</LastName>
            <ForeName>Kazuhiko</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology - Head &amp; Neck Surgery, Mie University Graduate School of Medicine, Tsu, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ohki</LastName>
            <ForeName>Motofumi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Kitasato University Medical center, Saitama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shimizu</LastName>
            <ForeName>Takeshi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology, Shiga University of Medical Science, Ootsu, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kurono</LastName>
            <ForeName>Yuichi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology - Head &amp; Neck Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Auris Nasus Larynx</MedlineTA>
        <NlmUniqueID>7708170</NlmUniqueID>
        <ISSNLinking>0385-8146</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009330" MajorTopicYN="N">Nebulizers and Vaporizers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012852" MajorTopicYN="Y">Sinusitis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword>
        <Keyword MajorTopicYN="N">Nasal inflammatory disease</Keyword>
        <Keyword MajorTopicYN="N">Nebulizer therapy</Keyword>
      </KeywordList>
      <CoiStatement>Conflict of interest The authors have no conflict of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
          <Hour>5</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34865941</ArticleId>
        <ArticleId IdType="pmc">PMC8606268</ArticleId>
        <ArticleId IdType="doi">10.1016/j.anl.2021.11.007</ArticleId>
        <ArticleId IdType="pii">S0385-8146(21)00269-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Yamanaka N, Iino Y, Uno Y, et al.  Drafting Committee for Acute Rhinosinusitis Management Guideline, Japanese Rhinologic Society. Practical guideline for management of acute rhinosinusitis in Japan. Auris Nasus Larynx. 2015;42:1â7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25043678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyo N, Takano H, Hyo Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. Rhinology. 1989;27:17â26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2740721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Work Group of the French Society of Otorhinolaryngology (SFORL)  Consensus document for prescription of nebulization in rhinology. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:371â374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25456242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saijo R, Majima Y, Hyo N, Takano H. Particle deposition of therapeutic aerosols in the nose and paranasal sinuses after transnasal sinus surgery: a cast model study. Am J Rhinol. 2004;18:1â7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15035564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg. 2002;127:558â568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12501108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takano N, Ohki M, Ogoshi T, Itoh M. Choice and practice of therapeutic medical devices in otorhinolaryngology. Jibiinkoka Tembo. 2012;55(Suppl. 1):32â39. [in Japanese]</Citation>
        </Reference>
        <Reference>
          <Citation>Ohki M, Hyo Y, Yoshiyama Y, et al.  Consensus guidance of nebulizer therapy for acute rhinosinusitis. Auris Nasal Larynx. 2020;47:18â24.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamada T, Saito H, Fujieda S, et al.  Efficacy of treatment to clean and widen the middle nasal meatus on rhinosinusitis. Pract OtorhinolaryngolâKyoto. 2002;95:153â157. [in Japanese]</Citation>
        </Reference>
        <Reference>
          <Citation>Kamijyo A, Matsuzaki Z, Kikushima K, et al.  Fosfomycin nebulizer therapy to chronic sinusitis. Auris Nasus Larynx. 2001;28:227â232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11489366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7:e35797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3338532</ArticleId>
            <ArticleId IdType="pubmed">22563403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fink JB, Ehrmann S, Li J, et al.  Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the international society of aerosols in medicine. J Aerosol Med Pulm Drug Deliv. 2020;33:300â304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7757542</ArticleId>
            <ArticleId IdType="pubmed">32783675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sethi S, Barjaktarevic IZ, Tashkin DP. The use of nebulized pharmacotherapies during the COVID-19 pandemic. Ther Adv Respir Dis. 2020;14:1â9.</Citation>
        </Reference>
        <Reference>
          <Citation>Garner JS, Favero MS. CDC guideline for handwashing and hospital environmental control 1985. Am J Infect Control. 1986;14:110â129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3014924</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34865941</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1476</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Auris, nasus, larynx</Title>
          <ISOAbbreviation>Auris Nasus Larynx</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Survey of nebulizer therapy for nasal inflammatory diseases in Japan before and during the COVID-19 pandemic.</ArticleTitle>
        <Pagination>
          <StartPage>504</StartPage>
          <EndPage>510</EndPage>
          <MedlinePgn>504-510</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anl.2021.11.007</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0385-8146(21)00269-8</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Nebulizer therapy is an effective and safe topical treatment for rhinosinusitis and is frequently used by otolaryngologists in Japan. However, treatment methods used vary among regions and according to doctors' preferences. In this study, we aimed to investigate the use of nebulizer therapy for rhinosinusitis. Administration of nebulizer therapy has been affected by the coronavirus disease 2019 (COVID-19) pandemic. Thus, we also investigated the difference in the prevalence of nebulizer use before and during the pandemic.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Between February and September 2016 and in January 2021, we administered questionnaire surveys on nebulizer treatment for rhinosinusitis to otorhinolaryngologists, who were members of the Oto-Rhino-Laryngological Society of Japan, in Aomori, Saitama, Mie, Fukui, Shiga, Okayama, and Kagoshima prefectures.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">More than 90% of the otorhinolaryngologists performed nebulizer treatment for rhinosinusitis in 2016. In April 2020 (the first wave of the COVID-19 pandemic), the use rate decreased to 20%, but in January 2021, the use rate increased to 60%. Jet nebulizers were the most frequently used type. One-third of the otolaryngologists enlarged the natural opening of the paranasal sinuses in more than half of their patients by using vasoconstrictors. Cefmenoxime and betamethasone were the most commonly used antibiotics and steroids, respectively.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Because it is important to perform nasal pretreatment and strict disinfection of nebulizer equipment, it is clear that education of otorhinolaryngologists as well as paramedical personnel is required to ensure safe and effective use of nebulizer therapy in Japan.</AbstractText>
          <CopyrightInformation>Copyright Â© 2021. Published by Elsevier B.V.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hyo</LastName>
            <ForeName>Yukiyoshi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology - Head and Neck Surgery, Kawasaki Medical School, Kurashiki, Japan; HYO ENT Clinic, Kyoto, Japan. Electronic address: yuki-hyo@med.kawasaki-m.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujieda</LastName>
            <ForeName>Shigeharu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Otorhinolaryngology - Head &amp; Neck Surgery, Department of Sensory and Locomotor Medicine, Faculty of Medical Science, University of Fukui, Fukui, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsubara</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Hirosaki University, Hirosaki, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takeuchi</LastName>
            <ForeName>Kazuhiko</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology - Head &amp; Neck Surgery, Mie University Graduate School of Medicine, Tsu, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ohki</LastName>
            <ForeName>Motofumi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Kitasato University Medical center, Saitama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shimizu</LastName>
            <ForeName>Takeshi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otorhinolaryngology, Shiga University of Medical Science, Ootsu, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kurono</LastName>
            <ForeName>Yuichi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology - Head &amp; Neck Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Auris Nasus Larynx</MedlineTA>
        <NlmUniqueID>7708170</NlmUniqueID>
        <ISSNLinking>0385-8146</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009330" MajorTopicYN="N">Nebulizers and Vaporizers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012852" MajorTopicYN="Y">Sinusitis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword>
        <Keyword MajorTopicYN="N">Nasal inflammatory disease</Keyword>
        <Keyword MajorTopicYN="N">Nebulizer therapy</Keyword>
      </KeywordList>
      <CoiStatement>Conflict of interest The authors have no conflict of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
          <Hour>5</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34865941</ArticleId>
        <ArticleId IdType="pmc">PMC8606268</ArticleId>
        <ArticleId IdType="doi">10.1016/j.anl.2021.11.007</ArticleId>
        <ArticleId IdType="pii">S0385-8146(21)00269-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Yamanaka N, Iino Y, Uno Y, et al.  Drafting Committee for Acute Rhinosinusitis Management Guideline, Japanese Rhinologic Society. Practical guideline for management of acute rhinosinusitis in Japan. Auris Nasus Larynx. 2015;42:1â7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25043678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyo N, Takano H, Hyo Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. Rhinology. 1989;27:17â26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2740721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Work Group of the French Society of Otorhinolaryngology (SFORL)  Consensus document for prescription of nebulization in rhinology. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:371â374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25456242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saijo R, Majima Y, Hyo N, Takano H. Particle deposition of therapeutic aerosols in the nose and paranasal sinuses after transnasal sinus surgery: a cast model study. Am J Rhinol. 2004;18:1â7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15035564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg. 2002;127:558â568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12501108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takano N, Ohki M, Ogoshi T, Itoh M. Choice and practice of therapeutic medical devices in otorhinolaryngology. Jibiinkoka Tembo. 2012;55(Suppl. 1):32â39. [in Japanese]</Citation>
        </Reference>
        <Reference>
          <Citation>Ohki M, Hyo Y, Yoshiyama Y, et al.  Consensus guidance of nebulizer therapy for acute rhinosinusitis. Auris Nasal Larynx. 2020;47:18â24.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamada T, Saito H, Fujieda S, et al.  Efficacy of treatment to clean and widen the middle nasal meatus on rhinosinusitis. Pract OtorhinolaryngolâKyoto. 2002;95:153â157. [in Japanese]</Citation>
        </Reference>
        <Reference>
          <Citation>Kamijyo A, Matsuzaki Z, Kikushima K, et al.  Fosfomycin nebulizer therapy to chronic sinusitis. Auris Nasus Larynx. 2001;28:227â232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11489366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7:e35797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3338532</ArticleId>
            <ArticleId IdType="pubmed">22563403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fink JB, Ehrmann S, Li J, et al.  Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the international society of aerosols in medicine. J Aerosol Med Pulm Drug Deliv. 2020;33:300â304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7757542</ArticleId>
            <ArticleId IdType="pubmed">32783675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sethi S, Barjaktarevic IZ, Tashkin DP. The use of nebulized pharmacotherapies during the COVID-19 pandemic. Ther Adv Respir Dis. 2020;14:1â9.</Citation>
        </Reference>
        <Reference>
          <Citation>Garner JS, Favero MS. CDC guideline for handwashing and hospital environmental control 1985. Am J Infect Control. 1986;14:110â129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3014924</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
